Osteosarcoma in Korean children and adolescents.
Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.
Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea.
Jun Ah
JA
Lee
Adolescents; Child; Korea; Osteosarcoma